Vincent Rajkumar Profile picture
Aug 8 9 tweets 3 min read
While patients with diabetes may feel let down and disappointed there are some reasons for hope for lower priced modern analog insulins.

1) @CivicaRx a non profit drug manufacturer is working to manufacture insulin.
2) California announced it will manufacture insulin. @reoxoo cnbc.com/amp/2022/07/08…
3) The US plan to keep insulin price to $35 for Medicare beneficiaries is still intact. It is part of the historic healthcare reforms passed yesterday.
4) I am hopeful @costplusdrugs acquires insulin to add to its portfolio of over 700 drugs that it offers at very low prices. @mcuban
5) If Medicare is paying $35 I think it will be hard for insurers, PBMs, manufacturers whoever to charge $300 to patients on private insurance or lack insurance. So eventually patients on private insurance will also benefit.
6) Several states have enacted laws to lower the cost of insulin and to provide emergency insulin. @NSmithholt12
7) Manufacturers are providing analog insulins at low cost. This is welcome and hope it continues.
8) Biosimilars are available. And there is hope for more.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vincent Rajkumar

Vincent Rajkumar Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @VincentRK

Aug 9
Patients with cancers such as myeloma and CLL will benefit greatly from new changes:

Out of pocket costs will be capped at $2000 starting 2025. A game changer. kff.org/medicare/issue… Image
Patients will start seeing benefit even in 2024. Patients pay 5% of the cost of the drug once they’ve spent about $7000 a year (the catastrophic threshold).

It’s not hard to hit catastrophic threshold quickly when drugs cost $15,000 a month.

This 5% cost sharing ends in 2024
But if copays are capped and Medicare cannot negotiate it will allow Pharma to hike prices even more rapidly. Why?

Coz it will effectively silence the most important voice against unreasonably high drug prices: the voice of patients. Since their cost will stay constant.
Read 5 tweets
Aug 7
Breaking: Finally it has happened. Senate has passed a bill that is almost certain to become law. What it does:

1) Allows Medicare to negotiate drug prices
2) Prevents price increases on drugs Medicare buys..
3) Caps out-of-pocket drug costs for seniors to max of $2000 per year
1) Medicare negotiation is critical. It is what all other developed countries do. I welcome this even though it s more modest than I wanted.
2) Preventing the ability of drug companies to increase prices on the same drug year after year is huge. This is something that will greatly benefit seniors and the public. What happened in the last decade, see below, will be slowed down.
Read 10 tweets
Aug 7
Insulin. Moments ago. US Senate #Insulin4All
57 votes is more than I thought. But unfortunately it did not pass for those with private insurance. Needed 60 votes because of the point of order. Capping insulin to $35 is not going to happen for those with insurance.
Still hoping for a miracle. @DemFromCT — your comment gives me some hope.

Watching. More on insulin here.
Read 5 tweets
Aug 7
If you want to know how powerful Pharma lobbying is, look no further than insulin.#Insulin4All

Though insulin costs 10 times more than in other countries, is needed for survival in diabetes, despite countless articles written, let’s see how many oppose capping the price to $35.
Insulin prices compared to prices of other things we use as well illustrated by @lollydaggle years ago.

Some states have acted. have introduced the oxymoronic idea of “authorized generics”. But we need a national solution.
Insulin is the Achilles heel of Pharma and PBMs. There is absolutely no justification.

mayoclinicproceedings.org/article/S0025-…
Read 10 tweets
Aug 6
Breaking: The Senate Parliamentarian has OK’d most of the provisions for prescription drug reform in the bill.

Means:
-Medicare will negotiate.
-Copays for seniors will be capped at $2000 per year. huffpost.com/entry/bc-us-co…
Medicare negotiation is critical for controlling prescription drug prices. A huge first step. @ASlavitt @DavidP4AD
Capping copays for seniors at $2000 per year is huge. Seniors are being crushed by high prescription drug prices.
Read 14 tweets
Aug 5
118 of the nations leading oncologists call for Medicare negotiation of prescription drug prices— as far back as 2015! Read the petition. @MayoProceedings

As people who lead trials of new drugs we know what hurts innovation and what doesn't.

1/
mayoclinicproceedings.org/article/S0025-…
This list includes a Who's Who of oncologists. The ones who led countless clinical trials for new cancer drugs. We know the game. @DrHKantarjian @CliffordHudis @MorieGertz @DrJulieVose @rosslevinemd
2/ Image
Medicare negotiation is good not only for seniors but the entire public.

We will have more truly innovative and effective drugs because Pharma will not have the easy way out that it currently does of high prices regardless of how good a drug is.
3/
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(